ES
Estrella Immunopharma, Inc.
ESLAW · NASDAQ
$0.06 -4.00% (-$0.00)
1M -10.18%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 548.74%
Asset turnover 0.00x
ROIC 131.75%
Debt
0 /100
High Current ratio 0.20x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
43 /100
Moderate EPS volatility 36.25%
Profitable years 0
Beta -0.09x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ESLAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Upcoming events
02 DEC
Earnings
Upcoming earnings report